ESR1 and cancer: For example, mutations in the ligand-binding domains (LBDs) of nuclear receptors (NRs), such as estrogen receptor α (ERα) and progesterone receptor (PR), are frequently found in multiple types of cancers, including breast and prostate cancers20–22.